BiotechTube
Home/Prescient Therapeutics/Melanie Farris
MF

Melanie Farris

Non‑Executive Director

Prescient Therapeutics

Therapeutic Areas

Oncology

Prescient Therapeutics Pipeline

DrugIndicationPhase
PTX-100Relapsed/refractory Cutaneous T‑Cell LymphomaPhase 2a
CellPrymeCAR‑T enhancement platformPreclinical
OmniCARUniversal CAR‑T platformPreclinical

Leadership Team at Prescient Therapeutics

DJ
Dr James Campbell
Non‑Executive Chairman
DA
Dr Allen Ebens
Non‑Executive Director
DE
Dr Ellen Feigal
Non‑Executive Director
DG
Dr Gavin Shepherd
Non‑Executive Director
ML
Melanie Leydin
Company Secretary
View full Prescient Therapeutics profile